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Antimicrobial peptide gramicidin S  
is accumulated in granules of 
producer cells for storage of 
bacterial phosphagens
Marina Berditsch1, Mareike Trapp1, Sergii Afonin2, Christian Weber1, Julia Misiewicz1, 
Joana Turkson1 & Anne S. Ulrich1,2
Many antimicrobial peptides are synthesized non-ribosomally in bacteria, but little is known about 
their subcellular route of biosynthesis, their mode of intracellular accumulation, or their role in the 
physiology of the producer cells. Here, we present a comprehensive view on the biosynthesis of 
gramicidin S (GS) in Aneurinibacillus migulanus, having observed a peripheral membrane localization 
of its synthetases. The peptide gets accumulated in nano-globules, which mature by fusion into larger 
granules and end up within vacuolar structures. These granules serve as energy storage devices, as they 
contain GS molecules that are non-covalently attached to alkyl phosphates and protect them from 
dephosphorylation and premature release of energy. This finding of a fundamentally new type of high-
energy phosphate storage mechanism can explain the curious role of GS biosynthesis in the physiology 
of the bacterial producer cells. The unknown role of the GrsT protein, which is part of the non-ribosomal 
GS synthetase operon, can thus be assumed to be responsible for the biosynthesis of alkyl phosphates. 
GS binding to alkyl phosphates may suggest its general affinity to phosphagens such as ATP and GTP, 
which can represent the important intracellular targets in pathogenic bacteria.
The cyclic gramicidin S (GS) is a prototypical peptide antibiotic, isolated from soil bacilli in the early 
1940s1,2. It contains two repeats of five amino acids, including the unusual ornithine and Dphenylalanine 
(cyclo[DPhe-Pro-Val-Orn-Leu]2). GS was one of the first natural compounds for which template-based 
non-ribosomal peptide synthesis was described3, but the localization of the synthetase is still unknown. Despite 
its unprecedentedly high accumulation in cells (up to 30% of dry cell weight), the cationic GS2+ molecule is only 
moderately soluble in water. It has an amphiphilic structure with a high affinity for cellular membranes. This char-
acteristic feature is the underlying reason for its action as an antimicrobial agent, as GS can not only physically 
destroy the barrier function of the lipid bilayer4,5, but it can also interfere with and displace membrane-bound 
proteins6,7. These deleterious effects, however, raise the intriguing question how the producing bacteria can pre-
vent themselves from getting damaged. Aneurinibacillus migulanus (former Bacillus brevis) is indeed resistant to 
the addition of external GS8.
An early study of the subcellular morphology of GS-producing cells did not find any GS-containing intracel-
lular structures in connection with its accumulation9. It was suggested that the walls of GS-producing cells, which 
carry acidic S-layer proteins, can accumulate GS and thereby neutralize the harmful effect of the peptide on the 
cells’ own respiratory membrane-bound proteins10,11. Once the organization of the GS biosynthesis operon was 
established, which contains three structural genes (grsA, grsB, grsT)12,13, the role of the GrsA and GrsB proteins 
was described as a GS-synthesizing multi-enzyme complex14,15. The GrsT protein shares homology with fatty acid 
thioesterases, but its function remains unknown12,16. In a series of experiments where the fermentation medium 
was supplemented with specific amino acids, the activity of the GS synthetases was reported to show a paradoxical 
response to 1% arginine17. This amino acid markedly enhanced the yield of GS, but inhibited the synthetase activ-
ity in the soluble fraction of the cells. At the same time, the enzymatic activity of the membrane fraction increased 
more than two-fold, hence a membrane attachment of the GS synthetase was proposed.
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Gramicidin S is assumed to play a role in the timing of A. migulanus spore outgrowth, and in their heat- 
and UV-resistance18,19. Based on the observation that the spores of GS-producing cells, but not of GS-negative 
mutants, are hydrophobic (as determined by adhesion to hexadecane), GS was suggested to be responsible for 
preventing their rehydration20. Indeed, spore germination can be enhanced by washing the spores (with SDS, 
ethanol, Ca2+), or by incubation at high pH. GS was thus proposed to bind to the external layers of spores to delay 
germination and outgrowth21.
Here, we provide a modified, comprehensive picture to explain how A. migulanus produces this unusual 
membrane-active peptide and why it accumulates high levels thereof. Based on the peripheral membrane local-
ization of its biosynthesis apparatus, the subcellular route of GS production can be described. An unparalleled 
role for GS in the physiology of A. migulanus is proposed, namely the stabilization of phosphagens as an energy 
resource.
Results
Visualization of granules in producer cells. To visualize the peptide, we compared the rough 
GS-producing phenotype of A. migulanus DSM 5759 with smooth non-producing cells of DSM 56688 after fluo-
rescent staining22. Because the dye 5(6)-carboxyfluorescein-N-hydroxysuccinimide ester binds to deprotonated 
NH2-groups, at pH 8.3 it can label the weakly basic ornithine side chains of GS molecules. Such staining had 
been applied earlier to sort GS-hyperproducing cells by means of fluorescence activated cell sorting (FACS)22, 
but FACS does not allow to localize the dye. Hence, we used fluorescence microscopy to directly resolve the 
stained structures on and within the cells. Since the dye cannot cross the plasma membrane, only GS molecules 
on the cell surface or those accessible to the dye via the periplasmic space should be stained. Indeed, in the 
non-producing phenotypes, only the cell envelope is stained, as expected, i.e. the S-layer proteins and membrane 
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Figure 1. Comparative microscopy of non-producing and GS-producing phenotypes of A. migulanus 
grown in G4/4 medium. (a) In the non-producing phenotype, fluorescence is limited to the cell surface.  
(b) In GS-producing cells, at an early stage the granular fluorescence near the cell envelope indicates the 
presence of GS. (c) The fluorescent granular material increases with GS production to a yield of 700 μ g/ml 
peptide. (d) Further accumulation of granular structures at a GS yield of 1350 μ g/ml. (e) Transmission electron 
microscopy of non-producing cells reveals only large electron transparent granules, i.e. polyhydroxyalkanoates 
(PHA). (f) At the beginning of GS biosynthesis, small electron dense nano-globules appear in the periplasmic 
space. (g) At later stages, a large vacuole at the apical pole gets filled with the electron dense nano-globules.
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the membrane (Fig. 1b–d), whose number and size increases with increasing GS accumulation (Fig. 1c,d). These 
findings suggest an accumulation of GS in the periplasmic space and a subsequent sequestration into these fluo-
rescent, presumably invaginated structures.
Transmission electron microscopy (TEM) of A. migulianus DSM 5759 provides better resolution and was used 
to confirm the presence of the observed granules and to discriminate the complex cell wall structure, consisting 
of outer S-layer proteins, peptidoglycans, and inner S-layer proteins9 (Fig. S1a,d). When the S-layer proteins were 
removed from GS-producing cells by treatment with acidic glycine buffer, precipitation and washing, a significant 
amount of GS was always found in the wash buffer. These results corroborate the expected binding of cationic 
GS to the acidic S-layer proteins9. Interestingly, in the TEM images we detected some previously undescribed 
electron-dense nano-structures that were present only in the GS-producing phenotypes (Fig. 1e–g). These intra-
cellular nano-globules must be related to GS production, as they correlate with the fluorescence data showing 
small fluorescent particles in tight association with the cell envelope (Fig. 1b,c). During the early stages of GS 
biosynthesis, the electron-dense structures are located primarily near the plasma membrane in the periplasmic 
space (Fig. 1f). Further biosynthesis leads to an accumulation of the nano-globules in regions expanding laterally 
and apically, both in the fluorescent and TEM images (Fig. 1d,g).
Remarkably, when GS-producing cells were grown in minimal phenylalanine-containing GATF1 medium23, 
they additionally developed lamellar oriented membrane stacks (LOMS, see Fig. 2a), previously unknown for 
heterotrophic bacteria. Their repeat distance of 4.5 nm is comparable to the thickness of the plasma membrane, 
and their immediate proximity to the nano-globules suggests a mutual correspondence. The LOMSs are seen to 
surround a vacuole that is filled with nano-globules (Fig. 2a). At early stages of GS-production, the nano-globules 
have a typical diameter of 5–50 nm. Over time, however, they fuse into larger round (100 × 100 nm2) or ellipsoid 
(100 × 200 nm2) granular structures with the same electron-dense nature (Figs 2b,c and S1c). The estimated sizes 
of the mature granules in the TEM and scanning electron microscopy (SEM) images are in good agreement 
(Figs 2b,c and S1c,e). The fusion of nano-globules into larger granules implies a maturation process (Fig. 2b), and 
it is tempting to speculate that they may contain the newly produced GS.
While the nano-globules are always present in GS-producing cells, the LOMS did not form when cells were 
grown in the G4/4 medium, which is optimal for GS production23. Instead, additional large electron-transparent 
granules are seen in this medium, resembling the well-known polyhydroxyalkanoate (PHA) granules24. 
These large structures are localized in close proximity to the vacuoles that are filled with the electron-dense 
nano-globules (Fig. 1g). The occurrence of different subcellular structures (PHA versus LOMS) suggests 
some variability in the subcellular organization of GS biosynthesis and in the energy management of the cells, 
depending on nutritional conditions. However, the maturation process of the nano-globules seems to be uni-
versal, as their successive enlargement is observed in both growth media (Fig. 2b,c). Interestingly, the mature 
electron-dense granules in several vegetative cells are observed in close proximity to the segregated DNA fila-
ments. This specific observation suggests that the putative GS-containing granules may be involved in the storage 
of high-energy phosphates for DNA biosynthesis (Fig. S1a,b). Given the high electron density of these granules, 
they cannot consist of GS alone but must also contain compounds with a high affinity to the heavy atoms used in 
staining, i.e. most likely phosphates as in the well-known osmiophilic polyphosphate granules.
Characterization of isolated granules. Whenever cells had shed their S-layer proteins and cracked, the 
SEM micrographs showed some granular material outside the cells (Fig. S1d,e). We suggest that this material 
corresponds to the nano-globules and fused granular structures observed in TEM. It was possible to prepare an 
aqueous milky suspension consisting of this granular material from the GS-producing cells collected at the end of 
fermentation, by sonicating the cells and employing differential centrifugation to separate them finally from the 
large PHA granules (Fig. S2a). In this suspension, the granular material was found to undergo strong aggregation 
with time (Fig. S2b). The initial average diameter of the particles in the freshly prepared suspension was 130 nm, 
Figure 2. Fusion of nano-globules into granules. (a) Lamellar oriented membrane stacks (LOMS) surround 
the vacuole at the apical pole of cells grown in GATF1 medium for 24 hours. The vacuole is loaded with nano-
globules of 5–50 nm diameter. (b) Fusion of globules into a large granule continues (GATF1, 48 hours).  
(c) Mature granule consisting of multiple globules (G4/4 medium, 30 hours).
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as estimated by light scattering (Fig. S2c). During overnight storage, it grew to 557 nm (60%) and 175 nm (40%) 
(Fig. S2d). However, 10 minutes sonication led to disaggregation and reduced the average size of the particles 
again down to 125 nm (Fig. S2e).
The accumulation of GS within the intact granules was unambiguously determined by HPLC (data not show), 
by functional antimicrobial and haemolytic assays of the granular suspension (Table 1), and by mass spectrom-
etry. Interestingly, MALDI spectra of the pelleted suspension (Fig. 3a) always showed – in addition to the GS 
parent ion (1139.2, [M]−) – some regular patterns of ions with higher m/z values, shifted by 154/168/182/196 
or 156/170/184/198/212 m/z. In these patterns, the ions are spaced by exactly 14 m/z, which corresponds to the 
mass of a methylene (CH2) segment. A plausible interpretation of these adduct ions may thus be an attachment 
of GS to a homologous series of alkylated compounds, possessing even and odd numbers of carbon atoms rang-
ing from 3 to 7. Given our earlier speculation that phosphate may be present in the granules, based on their 
TEM staining behaviour, the first mass ladder could correspond to propionyl/butyryl/pentyl/hexyl phosphates 
(154/168/182/196 Da), and/or phosphoenol pyruvate (168 Da). The second pattern may represent phosphorylated 
hydroxyalkanoates, e.g. hydroxybutyryl phosphate with a mass of 184 Da. Even though the assignment is tenta-
tive, the FAB spectrum of the granular material after GS extraction confirms the presence of a regular pattern of 
ions with a predominant mass of 169 Da ([168 + H]+) among the other masses (Fig. S3).
The electron-dense granules described in TEM micrographs of various bacteria are typically identified as 
polyphosphate storage granules25. Initially, we therefore hypothesized that the cationic GS2+ may interact with 
such anionic polyphosphates (PolyP), in a similar manner as the divalent cations that are known to stabilize 
PolyP26. To check this possibility, we analysed the isolated GS-containing granules by solid-state magic angle 
spinning (MAS) 31P-NMR to confirm the expected presence of such phosphate chains (Fig. 3b). Surprisingly, 
only the characteristic signals of terminal phosphate groups are seen (close to 0 ppm), but no PolyP signals could 
be detected at around − 20 ppm27. Instead, the simple mono-phosphorylated substrates suggested above based 
on the MALDI data are found to be fully compatible with the 31P-NMR data of the GS-granules. The signals 
of butyryl phosphate, phosphoenol pyruvate, and AMP are seen between + 5 and − 5 ppm, whereas PPi and 
the β -phosphates in ADP and ATP lie between − 10 and − 25 ppm (Fig. S4). The solid-state NMR data and the 
MALDI analysis thus corroborate our suggestion that the GS molecules in the granules are coordinated to a 
family of alkyl mono-phosphates and hydroxyalkyl mono-phosphates with different numbers of methylene units. 
The high affinity of the anionic phosphates for the cationic GS is obviously driven by electrostatics (Fig. 3c), but 
must also involve hydrophobic interactions between the alkyl groups and the hydrophobic face of the GS peptide.
To confirm the postulated interaction of GS with butyryl phosphate (BuP) as a representative partner, we 
studied the response of the liquid-state 31P-NMR phosphate signal of an aqueous BuP solution after its addition 
to dry GS. Mixtures were prepared with BuP and GS in the respective millimolar concentrations that are indi-
cated by the corresponding numbers in each BuP:GS ratio (Fig. 3d,e). BuP on its own is fully water soluble at 
4 mM (4:0 sample), but in the presence of 1 mM GS (4:1 sample) the BuP signal gets shifted up-field, indicating 
an interaction of the phosphate group with the peptide (Fig. 3d). In this sample and the consecutive series with 
lower BuP:GS ratios, a massive precipitate is seen in the NMR tubes (Fig. 3e). As the 31P-NMR signals are found to 
disappear due to line broadening (Fig. 3d), BuP must be part of the precipitate due to complex formation with GS. 
Interestingly, in the 1:4 sample, the precipitate becomes almost fully transformed into an opalescent suspension of 
nano-sized agglomerates, according to SEM data (not shown), which are too large to give an isotropic liquid-state 
31P-NMR signal.
Membrane localization of GS synthetases. The enzymatic activity of the native GS synthetases was 
characterized with an ATP-PPi exchange assay (Fig. 4a), using phenylalanine and leucine as substrates for GrsA 
and GrsB, respectively28. The GS-producing strain A. migulanus DSM 5759 was cultivated in G4/4 medium to 
the mid-exponential growth phase, and separated into a membranous and a cytoplasmic fraction. The enzy-
matic activity of the membrane fraction significantly exceeded that of the cytoplasmic fraction for both sub-
strates (Fig. 4a), and ATP-PPi exchange was generally more pronounced for GrsB (with leucine) than GrsA (with 
phenylalanine).
For further immunostaining experiments, we obtained polyclonal antibodies against the recombinant phe-
nylalanine adenylation domain (PheA), which comprises the first 600 amino acids of the GrsA synthetase. They 
were used to monitor the presence of GrsA in the cell fractions of samples collected at different time points by 
immunostaining. The characteristic 126 kDa band of GrsA was detected at the initial time points of GS produc-
tion, both in the cytoplasmic and membrane fractions of cells, grown in both G4/4 (Fig. 4b) and GATF1 (Fig. 4c) 
media. The cytoplasmic signal, however, vanished over time, while the signal in the membrane fraction remained 
strong throughout. Our observation that the synthetase machinery gets settled on a membrane supports earlier 
assumptions on its membrane localization17. Western blots confirmed that samples incubated with pre-serum did 
not show any non-specific signals, and no 126 kDa bands were detected in the logarithmic or stationary phases of 
Sample
MIC (μg/ml) for bacteria HC90 (μg/ml) for haematocrit
E. coli P. aeruginosa S. aureus E. faecalis S. mutans 0.25% 2.5%
GS solution 16 32 4 8 2 12 ± 3 28 ± 4
GS granules 16 64 4 8 2 38 ± 2 676 ± 48
Table 1.  Biological activity of GS granules. MIC was performed with three biological replicates in at least two 
independent experiments. HC90 data are means of three independent experiments ± s.d.
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the non-producing phenotypes (data not shown). Immunogold staining of fixed A. migulanus cells also showed 
independently that GrsA was localized at the plasma membrane, as hardly any gold particles were observed in the 
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Figure 3. GS binding to alkyl phosphates. (a) MALDI mass spectrum of isolated granules revealing the 
presence of GS ions and associated polymer-like adducts. The mass differences to GS and tentative assignments 
are shown. (b) Solid-state magic angle spinning 31P-NMR spectrum of the isolated granules (black trace) and 
of BuP powder (red trace), under 10 kHz sample rotation at ambient temperature. (c) Molecular representation 
of GS and several alkyl phosphates. The molecules are displayed with their solvent accessible surfaces, coloured 
according to electrostatics (blue – positive charge, red – negative charge). The molecular dimensions are 
drawn to scale, and electrostatic interactions are indicated by arrows. (d) Liquid-state 31P-NMR spectra of 
BuP:GS mixtures in aqueous suspension (black traces) and of a pure BuP solution (red trace). The millimolar 
concentrations correspond to the respective numbers given in the ratios. The dashed line corresponds to the 
reference chemical shift of pure BuP. (e) Appearance of the samples that were used to acquire the 31P-NMR 
spectra in panel (d) At elevated GS ratios the formation of an opalescent suspension is observed. The figures are 
representative of at least two independent experiments in every case.
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i.e. both were at/near the plasma membrane (Fig. S5a) and on/near the membrane of the vacuole (Fig. S5b). These 
findings clearly demonstrate that the GS biosynthesis apparatus is preferably associated with cellular membranes.
The distinct membrane affinity of the GS synthetases was further confirmed by characterizing the protein-lipid 
interactions and physico-chemical properties of the proteins involved. A direct lipid-protein overlay assay showed 
that the recombinant PheA-domain possesses a high affinity for cardiolipin (Fig. S6a), which constitutes up to 
25% of the total phospholipid in the plasma membrane of A. migulanus29. Additional support for the membrane 
localization comes from a simple hydrophobicity analysis30 of the adenylation domains in the GrsA and GrsB 
synthetases (see Table S1, not shown for GrsB). Namely, five to eight hydrophobic regions were identified in the 
PheA-domain, depending on the partitioning scale used. When these regions are shown superimposed on the 
crystal structure of PheA-domain31, the protein is seen to be distinctly amphipathic (Fig. S6b). This 3D model 
provides the structural rationale for postulating a peripheral membrane localization of the enzyme, such that at 
least one face of the protein is able to interact with the lipid bilayer of the plasma membrane.
Discussion
The enormous accumulation of GS in the producer cells (up to 30% of dry cell weight) is astounding. Given the 
high affinity of GS to bind to and permeabilize lipid membranes5,32, and in view of its dangerous potential to 
deactivate6,29 and delocalize7 membrane proteins, the question arises as to how GS can be stored without affecting 
the cells during biosynthesis. Based on its intrinsic affinity for anionic compounds, the binding of GS to S-layer 
proteins, phospholipids, and/or nucleic acids had been suggested9,33,34, but early TEM studies had not revealed 
any GS-containing subcellular structures that accumulate GS9. Here, we have demonstrated that specific granules 
containing GS and alkyl phosphates are formed in GS-producing phenotypes of A. migulianus to fulfil this task. It 
had been previously shown that GS biosynthesis is preceded by an elevation of the total lipid content35, while the 
intracellular pools of high-energy nucleotides in the cells are depleted upon GS production36. These observations 
fully support our findings, because extensive phosphorylation has to take place before the fatty acids are stored as 
alkyl phosphates in granules, in which they are stabilized by complex formation with GS. The tight, non-covalent 
interaction of GS with these high-energy alkyl phosphates protects them from spontaneous dephosphoryla-
tion. This novel concept of protection and storage may have unexpected implications for bacterial physiology 
in general. For instance, butyryl phosphate is known as a specific substrate in other spore-forming Firmicutes 
(Clostridium acetobutylicum), where this high-energy molecule - rather than ATP - acts as a direct phosphate 
donor for transcription factors37. The protection of butyryl phosphate and related molecules by binding to GS 
Figure 4. Membrane localization of GS-synthetases in A. migulanus DSM 5759 RC phenotype. (a) Activity 
of GrsA and GrsB synthetases in ATP-PPi exchange assays in the membrane (m) and cytoplasmic (c) fractions, 
which were isolated from cultures grown in G4/4 medium. Phenylalanine and leucine were used as substrates 
for GrsA and GrsB, respectively. Data are means of three independent experiments ± s.d. (b) Immunodetection 
of GrsA in the cytoplasmic and membrane fractions of cells grown in G4/4 medium. (c) Immunodetection of 
GrsA in the cytoplasmic and membrane fractions of cells grown in the minimal GATF1 medium. Data (b,c) are 
representative of two independent experiments, each. (d) Immunogold staining of GrsA in a GS producing cell 
from GATF1 medium. White arrows mark the 10 nm gold particles. The figure is representative of at least two 
independent experiments.
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(or other cationic peptides) could thus provide the producer cells with a mechanism for storing high-energy 
phosphates in the form of self-assembled peptide-alkyl phosphate complexes instead of the well-known polyphos-
phate granules. In addition, GS binding to alkyl phosphates suggests its general affinity to intracellular phospha-
gens (e.g. ATP, GTP), which GS can target in pathogenic bacteria. This affinity serves as additional factor in the 
previously described antimicrobial and anti-biofilm activity of GS38. Remarkably, the haemolytic effect of GS in 
granules is essentially lower than of GS in solution (Table 1) that could be very promising for the application of 
GS granular material as an antimicrobial formulation.
The involvement of alkyl phosphates in the formation of storage granules that accumulate GS allows us to 
speculate on the putative role of the GrsT protein. The grsT gene encodes a protein of 256 amino acids with 
unknown function, which is homologous to fatty acid thioesterases12,13,16. The fact that the transcription initiation 
site in the GS biosynthesis operon is located upstream of the grsT gene12 indicates the obligatory participation 
of the GrsT protein in GS production and/or accumulation. Notably, the active site of thioesterases, containing 
the catalytic motif GHSMG, is also present in acyltransferases16 and lipases39. Therefore, as a possible function 
for GrsT we suggest that this protein may catalyse the hydrolysis of fatty acyl chains from ACP and their subse-
quent phosphorylation, similar to the reaction of phosphate butyryltransferase (butyryl-CoA + phosphate < = > 
CoA + butyryl phosphate). In cells grown in GATF1 medium, the formation of LOMS may also be correlated with 
a lipase activity of GrsT for producing alkyl phosphates from phospholipids.
Our discovery of GS-containing granules in connection with the newly established localization of the GS 
synthetase now permits a fresh view on the subcellular organization of non-ribosomal GS biosynthesis. First, 
upon binding of the GS synthetase to the inner leaflet of the plasma membrane, GS is accumulated in small 
nano-globules that are collected in the periplasmic space (Figs 1f and 5a). Subsequently, membrane invaginations 
(Figs 1g and 5b) lead to the formation of vacuoles as a major repository of the nano-globules, which successively 
fuse with one another and grow in size (Figs 2 and 5c,d). Finally, in metabolically inactive dormant cells, the 
vacuoles tighten, and the membrane-enclosed mature granules remain in the vicinity of the coiled DNA (Figs 5e 
and S1b). They are ready to make their energy-rich phosphates available for DNA synthesis in the next cycle of 
replication.
These peculiar insights into the subcellular organization of the non-ribosomal peptide synthesis machinery in 
A. migulianus may have practical implications for the engineering of cell-free templated pathways for the produc-
tion of model peptides, as lipid membranes clearly play a key role in this process. Bacterial granules, containing 
antimicrobial peptides and high-energy alkyl phosphates, could be utilized in agriculture to enhance the phos-
phate status of soils, to affect plant pathogens and thereby favourably modulate plant resistance.
Materials and Methods
Bacterial strains and growth conditions. A. migulanus strains DSM 5759 and DSM 5668, were 
obtained from the German Collection of Microorganisms and Cell Cultures (DSMZ, Braunschweig, Germany). 
GS-producing rough convex phenotype (RC of DSM 5759) and non-producing smooth convex phenotype (SC 
of DSM 5668) were characterized previously8 and maintained as spore suspensions in 30% glycerol at − 20 °C. To 
preserve the phenotype characteristics, 1 ml of the amino-nitrogen-rich, yeast-peptone complex medium con-
taining 5 g/l amino-nitrogen23 was inoculated with 10 μ l of a spore suspension and cultivated at 37 °C without 
agitation for 48 hours. Then, the cells were plated on modified Luria broth agar medium, containing 10 g/l bac-
to-tryptone and 10 g/l yeast extract (giving 1 g/l amino-nitrogen), 5 g/l NaCl and 30 g/l agar-agar. At this stage, the 
colonies were controlled for phenotype stability23. Three to five-day-old colonies were used to inoculate chemi-
cally defined G4/4 or GATF1 media, described earlier23. Fermentation was performed under aeration (agitation 
at 220 r.p.m.) at 40 °C, until an optical density of 8–10 at 660 nm (OD660) was achieved.
The minimum inhibitory concentrations (MIC) of GS were determined via a broth microdilution procedure 
on the control strains40: Escherichia coli DSM 1103, Pseudomonas aeruginosa DSM 1117, Staphylococcus aureus 
DSM 1104, Enterococcus faecalis DSM 2570, as well as on Streptococcus mutans DSM 20523, which all were pur-
chased from DSMZ.
Figure 5. Postulated model for the subcellular organisation of GS biosynthesis in A. migulanus. (a) At the 
beginning, both GS synthetases (  depicts GrsA; , ,  and  rectangles represent the four modules of GrsB) 
are peripherally bound to the inner face of the plasma membrane. GS is segregated together with high-energy 
alkyl phosphates as electron dense nano-globules (black dots) into the periplasm. (b,c) Upon membrane 
invagination, the GS-containing nano-globules fill the emerging vacuole. (d) Within the vacuole, the small 
globules fuse into larger GS-containing granules. (e) In dormant cells, these granules are located in the region of 
coiled DNA.
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GS isolation and quantification. The isolation and quantification of GS was performed as previously 
described, by extraction from the cells with 50 % acidic ethanol and RP-HPLC8,23.
GS visualization by fluorescent staining of cells. At different cultivation times, samples were 
removed from the culture, diluted to 1 ml with an OD660 = 0.3, and centrifuged at 3,500 × g at room temper-
ature (RT). The pellet was washed twice and resuspended in fresh 150 mM NaHCO3 buffer, pH 8.3. The 
5(6)-carboxyfluorescein-N-hydroxysuccinimide ester dye was prepared as a 10 mg/ml stock solution in DMSO. For 
cell staining, 1 μ l of the stock solution was added to a 1 ml aliquot of suspended cells. After 30 min incubation at 37 °C 
with paused agitation, the cells were pelleted, washed twice in 150 mM NaHCO3 buffer, and resuspended in 20 μ l of 
the same buffer. The fluorescent structures and GS granules were observed using an Axioskop 40 light microscope 
(Carl Zeiss Light Microscopy, Göttingen, Germany), equipped with an “A-Plan” objective (100x/1.25 Ph3) and 
a fluorescence filter (type 09, λ ex 450–490, λ em 515).
Preparation of samples for electron microscopy. At defined cultivation time points, aliquots were 
removed and diluted to yield a 1 ml suspension with an OD660 of approximately 5. For removal of the S-layer pro-
teins, the biomass was incubated in glycine buffer (200 mM glycine/HCl, 5 mM MgCl2, 10 μ M glutathione, 250 μ M 
EDTA, pH 2.5) for 2 hours at RT. Unless otherwise stated, 150 mM sodium phosphate buffer (SPB, pH 7.2) 
was used to prepare the solutions for fixation and for the cell washing procedures. The cells were fixed in 2% 
glutaraldehyde for 2 hours at RT, followed by an overnight incubation in 0.2% OsO4 at 4 °C (for better contrast). 
Next, the cells were washed twice with SPB and twice with 30% ethanol, followed by staining for 2 hours with 
3% uranyl acetate in 30% ethanol. Gradual dehydration was performed using an ethanol-acetone series: 50% 
ethanol, RT, 10 min; 70% ethanol, 4 °C, overnight; 90% acetone, RT, 10 min; 100% acetone, RT (three times within 
2 hours). The samples were embedded in epoxy resin using the Embed-It low-viscosity epoxy kit (Polysciences, 
Eppelheim, Germany) or in acryl resin LR White (Sigma-Aldrich), which was polymerized en bloc. Ultrathin sec-
tions were prepared using a Leica EM UC6 ultramicrotome (Leica Mikrosystem, Wetzlar, Germany) and placed 
on formvar-coated grids (Plano, Wetzlar, Germany). For immunogold staining, the grids were first blocked in a 
2% fat-free BSA solution and incubated overnight with polyclonal PheA antibodies. Next, they were co-incubated 
with 10 nm sized gold-conjugated anti-rabbit antibodies (Sigma-Aldrich) for 1 hour, and contrasted with 1% ura-
nyl acetate. During immunostaining, SPB containing 0.05% Tween 20 was used. Transmission electron micros-
copy (TEM) was performed with a Zeiss 912 Omega (Oberkochen, Germany) microscope at 120 keV of electron 
flow. To optimize contrast, zero-loss energy filtering was applied.
For scanning electron microscopy (SEM), the cells were fixed in 2% glutaraldehyde, washed in SPB, and resus-
pended in ultrapure MilliQ water. A 1 μ l droplet was deposited on a silicon support (Plano, Wetzlar, Germany) 
and air-dried. Before SEM observation, a thin platinum layer of 1 nm was sputtered onto the sample using a 
high vacuum coating system Leica EM MED020 (Leica Microsystems, Wetzlar, Germany) to avoid charging by 
the microscope. The samples were observed with a Zeiss Supra 55VP microscope (Oberkochen, Germany). All 
reagents applied were of EM grade.
ATP-PPi exchange assay. Native GS synthetases were isolated from cells grown in the mid-exponential 
phase, as previously described12. The concentrations of the proteins in the cytoplasmic and membrane fractions 
were estimated using a NanoDrop spectrophotometer (Thermo Scientific, Wilmington, USA). To the 500 μ l reac-
tion mixtures, which contained 1 mM ATP, 5 mM DTT, 5 mM NaPPi ·10H2O, 10 mM Phe or Leu, and 250 μ g/ml 
enzyme, we added 100 μ l of a 50 mM aqueous [γ -32P] NaPPi ·10H2O solution and incubated for 1 hour. The 
remaining radioactivity was quenched by the addition of 750 μ l of termination solution (100 mM NaPPi ·10H2O, 
560 mM HClO4) supplemented with 1.6% (w/v) charcoal. After washing twice, the pellet was incubated in 
750 μ l of termination solution. Radioactivity was determined in 15 ml of LumaSafe Plus scintillation cocktail 
(PerkinElmer, Boston, USA) employing the liquid scintillation analyser Tri-Carb® 2100 (PerkinElmer).
Production of the PheA protein. The adenylation domain of GrsA synthetase (PheA protein) containing 
the first 600 amino acids of GrsA was expressed recombinantly in E. coli M15 cells using the pQE60 vector. 
Protein purification was performed via Ni2+ affinity chromatography, followed by TEV cleavage of the His-tag 
and size-exclusion chromatography. Purity was checked by SDS-PAGE. The purified protein was used to produce 
the polyclonal antibody in rabbits (BioCat, Heidelberg, Germany).
Western blotting. A. migulanus cells were cultivated to defined time points and diluted to 1 ml cell 
suspensions with an OD660 = 4. The cells were washed and resuspended in 5 ml of buffer (50 mM Tris-HCl, 
20 mM MgCl2, 1 mM glutathione, 0.2 mM EDTA, pH 7.4) for disruption via sonication on ice. After separa-
tion from the cell debris by centrifugation for 15 minutes at 3,000 × g, the membrane and cytoplasmic frac-
tions were obtained by centrifugation for 1 hour at 100,000 × g. The cytoplasmic proteins were precipitated 
with 100% acetone overnight at − 20 °C. Both fractions were diluted in 60 μ l of SDS sample buffer. The proteins 
were separated by SDS-PAGE and transferred to a Protran BA83 nitrocellulose membrane (Sigma-Aldrich) for 
Western blotting. Immunodetection was performed with the polyclonal antibodies against PheA and alkaline 
phosphatase-conjugated anti-rabbit antibodies (Invitrogen, Darmstadt, Germany) according to manufacturer’s 
instructions. Control blots were performed with the corresponding pre-serum.
Lipid-protein overlay assay. The lipid-protein overlay assay was performed using the protocol reported in 
ref. 41. Briefly, the lipids were dissolved in chloroform/methanol (7:3 vol:vol) to yield 16.7 mg/ml solutions. 3 μ l of 
each lipid solution was spotted on a nitrocellulose membrane filter with a pore size 0.45 μ m, and dried for 1 hour. 
Free binding sites were blocked with 3% fat-free BSA. After washing with SPB buffer supplemented with 0.05% 
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Tween 20 and fat-free 3% BSA, the membrane was incubated in the PheA protein solution (10 μ g/ml) overnight 
at 4 °C. Immunodetection was performed as described for the Western blot.
Hydrophobicity analysis. The hydropathy of the PheA protein was analysed using Membrane Protein 
Explorer (MPEx 3.2)30. Regions in the PheA sequence that were identified as potential membrane-interacting 
segments simultaneously in the “interfacial” and the “octanol” whole-residue partitioning scales were visualized 
in the crystal structure of the PheA protein31 using Discovery Studio 3.0 software from BIOVIA.
Isolation and characterization of GS granules. Bacterial cells cultured in G4/4 media were harvested 
in the stationary phase by centrifugation at 6,000 × g (4 °C, 15 min) and washed twice in physiological saline solu-
tion. The biomass was concentrated 20-fold in buffer containing 50 mM Tris-HCl (pH 7.2), 1 mM glutathione, 
1 mM MgCl2/6H2O and 0.2 mM EDTA. Then, the cells were sonoporated on ice (twice for 3 min) to release the 
cell contents. The yield of the granular material was controlled microscopically. The cell debris was pelleted 
for 10 min at 600 × g, and the supernatant was consecutively applied to differential centrifugation at 2,000 × g, 
5,000 × g and 9,000 × g (each step for 10 min at 4 °C). The last supernatant was treated with Benzonase® Nuclease 
(Sigma-Aldrich) for 1 hour at RT and overnight at 4 °C, and then centrifuged at 100,000 × g for 30 minutes at 4 °C. 
The transparent, yellowish pellet was resuspended in sterile ultrapure MilliQ water and lyophilized for storage.
For analysis, this powder of GS granules was dispersed in water to obtain an opaque colloidal liquid. After 
centrifugation of the granules at 17,000 × g for 3 min, the pellet was dissolved in either acidic 50% ethanol (con-
taining 20 mM HCl) or acidic DMSO (containing 0.1% trifluoroacetic acid). HPLC was used to quantify the GS 
content. The size homogeneity of the granules was examined using a Nano S Zetasizer (Malvern Instruments, 
UK).
Suspensions of the GS granules were prepared to contain 1 mg/ml of GS in water or 4 mg/ml of GS in isotonic 
buffer (Tris-HCl 172 mM, pH 7.6 at 37 °C), in order to determine the antimicrobial and haemolytic activities, 
respectively. For MIC tests, the standard broth microdilution assay was performed in microtiter plates using 
Mueller Hinton medium as described earlier38. MIC was performed with three biological replicates in at least 
two independent experiments. For haemolytic activity, human blood in citrate-phosphate-dextrose buffer was 
obtained from the blood transfusion department of the municipal hospital in Karlsruhe, washed twice in isotonic 
Tris-HCl wash-buffer (pH 7.6, RT), and diluted to 0.5 or 5% of haematocrit in Tris-HCl reaction-buffer (pH 7.6, 
37 °C). GS was prepared as an aqueous solution with a concentration of 800 μ g/ml by adding 1/10 volume of 
DMSO and then 9/10 volume of Tris-HCl reaction-buffer. This GS solution or a suspension of GS granules were 
diluted 1:1 in Tris-HCl reaction-buffer to an end volume of 200 μ l, then 200 μ l erythrocyte suspension were added 
to start the haemolytic reaction (37 °C, paused agitation, 30 minutes). The studied concentrations were in the 
range of 5–200 μ g/ml for the GS solution, and 10–1000 μ g/ml for the suspension of GS granules. After centrifu-
gation, the 350 μ l supernatant containing the released haemoglobin, was characterized in a spectrophotometer at 
540 nm. The haemolytic concentrations (HC90) were calculated as the percentage haemolysis compared to 100% 
induced by 0.1% Triton X-100.
For MALDI-TOF mass spectrometry, an initial aqueous suspension of GS granules was centrifuged 
(17,000 × g for 3 min at RT), and the pellet was redissolved in a small amount of acidic DMSO. 1–2 μ l of the 
resulting sample were co-crystallized with 2,5-dihydroxybenzoic acid (1:2 vol:vol water:acetonitrile, 0.1% TFA). 
The spectra were collected on a Bruker Autoflex III instrument, employing a negative ion acquisition mode and a 
reflectron in the spectral window of 800–4000 Th.
For FAB mass spectrometry, the pellet of GS granules was treated with acidic 50% ethanol, containing 20 mM 
HCl, heated at 80 °C for 15 minutes, and then agitated for 1 hour at 30 °C. After centrifugation the pellet was 
dissolved in glycerol and measured in negative mode using FAB spectrometer MAT95 (MasCom, Bremen, 
Germany).
31P-NMR spectroscopy. The pellet of GS granules was washed twice in MilliQ water and dried at ambi-
ent temperature. A powder of the GS granules and the butyryl phosphate di-lithium salt (Toronto Research 
Chemicals, North York, Canada) were each packed into a 4 mm ceramic rotor (Bruker) and measured at RT using 
a Bruker HXY 4 mm MAS probe on a Bruker AVANCE 500 MHz spectrometer equipped with a wide-bore mag-
net. Solid-state magic angle spinning (MAS) 31P-NMR spectra were collected at variable spinning rates (2–16 kHz) 
at a 202.4 MHz operating frequency, employing a single-pulse (2.9 μ s) experiment, with continuous-wave 1H 
decoupling. At least 16 scans were accumulated for each spectrum, with an inter-pulse delay of 5 s. The spectra 
were processed with TopSpin 3.1 software.
To determine the binding affinity of GS to butyryl phosphate, GS aliquots, calculated for 1, 2 and 4 mM con-
centrations in 600 μ l, were lyophilized in 2 ml glass vessels. A freshly prepared 600 μ l of 4 mM, 2 mM and 1 mM 
butyryl phosphate (BuP) solutions in D2O (pD 7.2) were added to the appropriate amount of GS, in order to cre-
ate a range of molecular ratios of BuP:GS of 4:1, 2:1, 1:1, 1:2 and 1:4. A sample of pure 4 mM GS was also prepared 
to demonstrate the low solubility of this peptide in Fig. 4e. Each NMR sample was incubated at RT for at least 
2 hours to allow any pellet to precipitate. Each measured reference compound (0.2 mM) was prepared in MilliQ 
water mixed with 10% D2O (Fig. S4). Proton-decoupled 31P-NMR spectra were acquired on a Bruker AVANCE 
400 MHz spectrometer operating at a 31P frequency of 161.9 MHz. The experiments were performed at RT using a 
Bruker 5 mm BB-PABBO probe. A single-pulse (15 μ s) experiment was performed. For 1H decoupling, a waltz16 
decoupling sequence was used. 3500 scans were accumulated for each spectrum, with an inter-pulse delay of 2 s. 
The spectra were processed with TopSpin 3.1 software.
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